Home
About Us
Knowledge
Products
Business
Newsroom
Careers
Contact Us
Home
About Us
Company profile
Corporate culture
Knowledge
Drug instructions
Literature
Laws and regulations
Products
All
Drugs
Medical Devices
Health Care Product
Cosmeceuticals
Active Pharmaceutical Ingredients
Business
Newsroom
Company news
Media coverage
Careers
Employing
Recruit
Contact Us
NEWS CENTER
Home
Newsroom
Company news
Media coverage
2026.08.14
FDA Approves New Viral Immunotherapy for Treatment-Resistant Advanced Melanoma
View all
2026.08.06
FDA Approves First Drug Targeting Root Cause of Narcolepsy Type 1
View all
2026.07.27
EMA Recommends EU Approval of Susvimo as New Treatment Option for Wet Age-Related Macular Degeneration
View all
2026.07.27
EMA Recommends First Oral IL-23 Receptor Medicine for Plaque Psoriasis
View all
2026.07.17
European Medicines Agency Issues Two Drug Safety Alerts
View all
2026.06.30
EMA Recommends Revoking Marketing Authorisation for Tavneos (Avacopan)
View all
«
1
2
3
4
...
9
»
